
Asher Bio
We build better immunotherapies
Monthly revenue–Not shared yet
Rank–Unranked
Last 30 days–Growth in MRR
Revenue per founder–– founders
About Asher Bio
Asher Bio is a biotechnology company developing precisely targeted immunotherapies for cancer and other diseases. Our cis-targeting platform aims to enable selective activation of specific immune cell types, addressing the inherent limitations of otherwise pleiotropic immunotherapies that act on multiple cell types. Our approach has the potential to precisely direct different immune mediators against a range of target immune cell-types and create best-in-class immunotherapies in cancer, autoimmune and infectious diseases. Asher Bio is backed by Third Rock Ventures and is located in South San Francisco.
Discover more startups
Browse the board →MRR
$250K
Last 30 days
0%
Founder
Valon Asani
MRR
$250K
Last 30 days
0%
Founder
Charlie Choi
MRR
$250K
Last 30 days
–
Founder
Nicolas Vandenberghe